JTCS Speed Up Your Browser
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
David M. Shahian
Warren A. Williamson
David T. Martin
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shahian, D. M.
Right arrow Articles by Ellis, J. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shahian, D. M.
Right arrow Articles by Ellis, J. R.

J Thorac Cardiovasc Surg 1995;110:1013-1022
© 1995 Mosby, Inc.


SURGERY FOR ACQUIRED HEART DISEASE

THE ROLE OF CORONARY REVASCULARIZATION IN RECIPIENTS OF AN IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR

David M. Shahian, MD, Warren A. Williamson, MD, Ferdinand J. Venditti, Jr., MD, David T. Martin, MD, Jonathan R. Ellis, MD


Burlington, Mass.

From the Department of Thoracic and Cardiovascular Surgery and the Section of Cardiology, Lahey Clinic Medical Center, Burlington, Mass.

Received for publication June 15, 1994. Accepted for publication Dec. 29, 1994. Address for reprints: David M. Shahian, MD, Department of Thoracic and Cardiovascular Surgery, Lahey Clinic Medical Center, 41 Mall Rd., Burlington, MA 01805.

Abstract

The impact of adjuvant coronary revascularization was studied in a group of 138 recipients of an implantable cardioverter-defibrillator, all of whom had ischemic heart disease as the cause of their arrhythmias. Patients chosen for revascularization had more severe anatomic, symptomatic, or physiologic evidence of active ischemia. There were no operative deaths among 23 patients who actually underwent coronary artery bypass combined with cardioverter-defibrillator implantation; however, operative mortality by the intention-to-treat principle was 8% (2/25). Total cardiac survival was better for patients who underwent revascularization than for those patients who had "high-risk"characteristics and did not undergo revascularization. Stratified subgroup analysis demonstrated significant survival advantages favoring revascularization in patients with three-vessel or left main coronary artery disease, class III or IV angina, and an ejection fraction greater than 25%. Multivariate analysis revealed that low ejection fraction and left main coronary artery disease were independent predictors of decreased survival. (J THORACCARDIOVASCSURG1995;110:1013-22)







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1995 by The American Association for Thoracic Surgery.